Dec 04, 2019 / 02:30PM GMT
Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division - Associate
All right. So I think we'll get started. Hi, everybody. Good morning. Welcome. I'm Elizabeth Anderson. I'm the healthcare tech and distribution analyst at Evercore ISI, and I am joined by the illustrious Jim Foster, CEO of Charles River.
So the way I was thinking about doing this, I have a bunch of questions, but if you have questions, you can feel free to interject, and we'll go from there.
All right. Well, thank you. Welcome.
James C. Foster - Charles River Laboratories International, Inc. - Chairman, CEO & President
Nice to be here.
Questions and Answers:
Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division - AssociateSo as I get started, I will start off with the obligatory biotech funding question, which I'm sure you could probably answer in your sleep at this time. But sort of what leading indicators do you look at as you sort of monitor biotech funding? I